155 related articles for article (PubMed ID: 24994098)
21. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary colorectal cancer].
Möslein G
Chirurg; 2008 Nov; 79(11):1038-46. PubMed ID: 18853126
[TBL] [Abstract][Full Text] [Related]
23. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Fukunari H; Tanaka K; Miyaki M
Cancer Res; 1992 Jul; 52(13):3801-3. PubMed ID: 1319833
[TBL] [Abstract][Full Text] [Related]
24. [Application of serum protein markers to distinguish familial adenomatous polyposis (FAP) and sporadic colorectal adenomas].
Cai SR; Yu JK; Jiang WZ; Zhang SZ; Zheng S
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):192-5. PubMed ID: 19615258
[TBL] [Abstract][Full Text] [Related]
25. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
[TBL] [Abstract][Full Text] [Related]
26. Pathways of colorectal carcinogenesis.
Arends MJ
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):97-102. PubMed ID: 23417071
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
[TBL] [Abstract][Full Text] [Related]
28. Lynch or not Lynch? Is that always a question?
Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study.
; Müller A; Beckmann C; Westphal G; Bocker Edmonston T; Friedrichs N; Dietmaier W; Brasch FE; Kloor M; Poremba C; Keller G; Aust DE; Fass J; Büttner R; Becker H; Rüschoff J
Int J Colorectal Dis; 2006 Oct; 21(7):632-41. PubMed ID: 16511680
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
[TBL] [Abstract][Full Text] [Related]
31. Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22.
Bläker H; Mechtersheimer G; Sutter C; Hertkorn C; Kern MA; Rieker RJ; Penzel R; Schirmacher P; Kloor M
Genes Chromosomes Cancer; 2008 Feb; 47(2):159-64. PubMed ID: 18008368
[TBL] [Abstract][Full Text] [Related]
32. Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.
Dominguez-Valentin M; Therkildsen C; Veerla S; Jönsson M; Bernstein I; Borg A; Nilbert M
PLoS One; 2013; 8(8):e71755. PubMed ID: 23951239
[TBL] [Abstract][Full Text] [Related]
33. Congenital genetic instability in colorectal carcinomas.
Svendsen LB
Dan Med Bull; 1993 Nov; 40(5):546-56. PubMed ID: 8299399
[TBL] [Abstract][Full Text] [Related]
34. Pathology and genetics of hereditary colorectal cancer.
Ma H; Brosens LAA; Offerhaus GJA; Giardiello FM; de Leng WWJ; Montgomery EA
Pathology; 2018 Jan; 50(1):49-59. PubMed ID: 29169633
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Igari T; Tanaka K; Muraoka M; Takahashi H; Amada Y; Fukayama M
Cancer Res; 1994 Jun; 54(11):3011-20. PubMed ID: 8187091
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer with and without microsatellite instability involves different genes.
Salahshor S; Kressner U; Pâhlman L; Glimelius B; Lindmark G; Lindblom A
Genes Chromosomes Cancer; 1999 Nov; 26(3):247-52. PubMed ID: 10502323
[TBL] [Abstract][Full Text] [Related]
38. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
Gallinger S; Vivona AA; Odze RD; Mitri A; O'Beirne CP; Berk TC; Bapat BV
Oncogene; 1995 May; 10(9):1875-8. PubMed ID: 7753564
[TBL] [Abstract][Full Text] [Related]
39. Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
Pakish JB; Zhang Q; Chen Z; Liang H; Chisholm GB; Yuan Y; Mok SC; Broaddus RR; Lu KH; Yates MS
Clin Cancer Res; 2017 Aug; 23(15):4473-4481. PubMed ID: 28264871
[No Abstract] [Full Text] [Related]
40. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
Soravia C; Bapat B; Cohen Z
Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
